Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02059356 · ClinicalTrials.gov registry record
Ammonia Levels and Cognitive Impairment
A clinical trial, sponsored by Duke University.
- Terminated
- Registry status
- 17
- Enrollment target
NCT02059356 is a clinical trial that was terminated before completion, run by Duke University. The registered enrollment target is 17 participants.
The verdict
NCT02059356 was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The purpose and objective of this study is to determine the prevalence of elevated ammonia levels in subjects with cognitive impairment, and to observe if treating the cause of the elevated ammonia level improves mental status. This study does not include any imaging, treatment,or interventions, other than the blood draws. The blood draws will be taken to assess blood ammonia level and liver function. If the the ammonia level is not elevated, no further lab draws will occur. If the ammonia level is elevated, liver function is normal, and a cause for the high ammonia level is revealed with a plan for clinical treatment by the subjects' physician, then two more blood draws will occur; one prior to treatment, and one 3 months after treatment. The main risk to subjects is related to the blood draw (i.e. momentary discomfort, bruising, infection, bleeding, clotting or fainting), and there is a potential loss of confidentiality. A paired student t test will be done with the two later blood to compare objective data.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02059356
The ClinicalTrials.gov registry entry for NCT02059356 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02059356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02059356 about?
NCT02059356 is a clinical study titled "Ammonia Levels and Cognitive Impairment". The purpose and objective of this study is to determine the prevalence of elevated ammonia levels in subjects with cognitive impairment, and to observe if treating the cause of the elevated ammonia level improves mental status. This study does not include any imaging, treatment,or interventions, oth...
What is the current status of trial NCT02059356?
This trial is currently terminated. The enrollment target is 17 participants. The study started on 2014-01.
Who is sponsoring clinical trial NCT02059356?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.